Ozempic, Mounjaro and Wegovy are medications which contain the active ingredient semaglutide. Primarily prescribed to treat type 2 diabetes in adults and reduce the risk of cardiovascular problems, Ozempic, Mounjaro, and Wegovy have recently been widely prescribed to help with weight loss. These drugs mimic the glucagon-like peptide-1 receptor agonist (“GLP-1 RAs") hormone in the body, which increases insulin secretion and helps regulate blood sugar levels.
Recent studies have shown that semaglutide medications such as these may increase the risk of gastroparesis, also known as stomach paralysis. Gastroparesis is a condition affecting the stomach muscles that slows or stops the movement of food from your stomach to your small intestine. Normally, a person’s stomach empties within two to four hours after a meal. In patients taking Ozempic, Mounjaro, or Wegovy, it can take ten to eighteen hours for the stomach to empty.
Ozempic-induced gastroparesis may lead to poor absorption of nutrients, which can cause malnutrition, dehydration, and difficulty maintaining blood sugar levels. Patients may experience:
The warning labels on these medications fail to mention these potential side effects, exposing all users to unnecessary risk.
If you or a loved one have any of the related health issues linked to Ozempic, Mounjaro or Wegovy, you may be entitled to compensation. The attorneys at Nachawati Law Group are dedicated to holding negligent pharmaceutical companies responsible for the harm they cause. Please contact us today for a free consultation.
We prosecute pharmaceutical and medical device injuries. Every day, we…
Auto accidents occur on Texas roads approximately every 67 seconds,…
The position will involve litigating product liability cases throughout all phases, from filing to trial. The job requires strong legal research and writing skills and a solid grasp of civil procedure.
Responsibilities
Responsibilities